19:12:26 EDT Wed 24 Apr 2024
Enter Symbol
or Name
USA
CA



Veritas Pharma Inc (2)
Symbol VRT
Shares Issued 12,157,399
Close 2019-12-06 C$ 0.19
Market Cap C$ 2,309,906
Recent Sedar Documents

Veritas Pharma closes sale of Sechelt property

2019-12-09 08:37 ET - News Release

Mr. Peter McFadden reports

VERITAS ANNOUNCES THE SALE OF THE SECHELT PROPERTY

Veritas Pharma Inc.'s fully owned subsidiary, the Sechelt Organic Marijuana Corp., has completed the sale of its property located in Sechelt, B.C., to Lis Holdings Ltd. for cash consideration of $350,000.

This property was originally purchased in February, 2015, with plans to construct a medical cannabis production facility under the ACMPR (access to cannabis for medical purposes regulations) program. However, due to significant and unforeseen changes to the licensing requirements the property could no longer qualify for the intended use. Veritas interim chief executive officer Peter McFadden commented: "This asset no longer provided any strategic value to our shareholders, as such we believe it to be prudent to sell the asset. It has been our aim to consolidate the company's assets to assets with potential to provide revenue within near to medium term."

About Veritas Pharma Inc.

Veritas Pharma is an emerging pharmaceutical and IP development company, which, through its 100-per-cent-owned subsidiary, Cannevert Therapeutics Ltd. (CTL), is advancing the science behind medical cannabis.

© 2024 Canjex Publishing Ltd. All rights reserved.